Small Molecule Bioanalysis Services

Pharmaron provides comprehensive global small molecule bioanalysis services to drug R&D programs, spanning from discovery through preclinical to clinical development phases. The analytes include traditional small molecules, nucleotides/nucleosides, oligonucleotides, peptides, carbohydrates, oligosaccharides, lipids and other non-Lipinski-rule-of-five molecules, etc. Our team of experts work together with our partners to design and implement a mission-driven bioanalysis strategy. Well-trained and highly experienced teams use state-of-the-art instrumentation and leading-edge technologies to deliver high-quality bioanalytical data in a timely manner to support the rapid progress of drug discovery and development projects. For data that is used for regulatory filings in support of IND, NDA and ANDA applications, FDA/EMA/NMPA/ICH regulatory guidelines including GLP/GCP/GCLP will be followed.

Learn more about Pharmaron’s small molecule bioanalytical services

Capabilities

Discovery Bioanalysis of Small Molecules

Preclinical Bioanalysis of Small Molecules

Clinical Bioanalysis of Small Molecules

Related Services

Lab chemistry researchers looking at paperwork

Learn more about Pharmaron’s laboratory chemistry services

Under the leadership of an experienced synthetic and medicinal chemistry management team, thousands of chemists are synthesizing compounds in a timely and cost-effective manner to meet the needs of our partners.

Learn more about Pharmaron’s integrated drug discovery and development services

Pharmaron provides a complete integrated platform from drug discovery to proof of concept (“POC”). Our industry knowledge, strong execution tactics and end-to-end solutions shorten the drug discovery and development cycle.